.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Scientists at the National Institute of Nutrition (NIN) recently developed a poly-herbal blend for diabetes and obesity management. This innovative formulation combines five common kitchen ingredients: ginger, cinnamon, black pepper, amla, and turmeric. Beyond simple glucose control, the extract targets inflammation and oxidative stress. Consequently, it addresses the root causes of long-term diabetic complications that affect the heart and kidneys.
Researchers selected these five herbs after screening nearly 200 functional foods. They specifically focused on inhibiting advanced glycation end products (AGEs). These compounds contribute significantly to chronic damage in patients with diabetes. The team tested each ingredient individually before establishing a precise, scientifically backed composition. Furthermore, preclinical studies showed promising results in reducing both blood glucose and body weight. Because it is not a random mixture, the formulation ensures consistent potency.
The National Institute of Nutrition clarifies that this extract serves as an add-on therapy. It is not a replacement for standard medical treatments like metformin or insulin. Instead, it offers a protective effect for the eyes, nerves, and vascular system. Currently, the formulation is standardized at the laboratory level. Human clinical trials are scheduled to begin shortly and will likely last up to a year. This development highlights a significant move toward integrative health solutions in India. Doctors may soon have a scientifically validated herbal tool to complement existing diabetic care plans.
Q1: What specific ingredients comprise this new formulation?
The extract consists of a precise, evidence-based blend of ginger, cinnamon, black pepper, amla, and turmeric.
Q2: Can this herbal blend replace existing diabetes medication?
No, researchers emphasize that the blend is intended as an add-on therapy to existing clinical treatments, not a substitute.
Q3: How long will the clinical trials for this extract take?
The clinical trials are expected to run for 9 to 12 months, with a full evaluation completed within 18 months.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NIN scientists develop a poly-herbal extract using five common herbs to manage diabetes, obesity, and long-term complications through scientific integration...
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
